Le Lézard
Classified in: Health, Science and technology, Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory

Harrow Will Release Fourth Quarter and Year-End 2023 Financial Results After Market Close on March 19, 2024


Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that it will release its financial results for the fourth quarter and year ended December 31, 2023, on Tuesday, March 19, 2024, after the market close. The Company will also post its fourth quarter Letter to Stockholders to the "Investors" section of its website, harrow.com. Harrow will host a conference call and live webcast at 8:00 a.m. Eastern Time on Wednesday, March 20, 2024, to discuss the results and provide a business update.

Conference Call Details:

 

Date:

Wednesday, March 20, 2024

Time:

8:00 a.m. Eastern time

Participant Dial-in:

1-833-953-2434 (U.S.)
1-412-317-5763 (International)

Replay Dial-in (Passcode 6766979):

(telephonic replay through March 27, 2024)

1-877-344-7529 (U.S.)
1-412-317-0088 (International)

Webcast: (online replay through March 20, 2025)

harrow.com

About Harrow

Harrow, Inc. (Nasdaq: HROW) is a leading eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products for the North American market. Harrow helps eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of patients each year. For more information about Harrow, please visit harrow.com.


These press releases may also interest you

at 18:54
Emerald ash borer confirmed in Vancouver, British Columbia
The Canadian Food Inspection Agency (CFIA) has confirmed the presence of emerald ash borer (EAB - Agrilus planipennis) in the City of Vancouver, British Columbia. These detections, which are outside of currently regulated areas for emerald ash borer...

at 18:35
Teva to Present at the 2024 Bank of America Healthcare Conference
Teva Pharmaceutical Industries Ltd. today announced that Richard Francis, Teva's President and CEO, will present at the 2024 Bank of America Healthcare Conference on Tuesday, May 14, 2024. The presentation will begin at 8:40 A.M. Pacific Time (11:40...

at 18:32
TOTAL POINT HEALTH CARE SYSTEMS, INC. BRINGS ACCESSIBLE HEALTHCARE TO TEXAS
Total Point Healthcare Systems, Inc. is on a mission to bring quality, affordable medical care to the states of Texas, Missouri, and Arizona. Established by Jeffrey Love, a new investor with extensive experience in the tech ecosystem Bijaya Karki,...

at 18:15
Andlauer Healthcare Group Reports 2024 First Quarter Results
Andlauer Healthcare Group Inc. ("AHG" or the "Company") today reported its financial results for the three-month period ended March 31, 2024 ("Q1 2024"). Q1 2024 Summary Revenue totaled $161.1 million, a decrease of 2.2% from $164.8 million for the...

at 18:02
AHRC Nassau's 75th Anniversary Spotlights History of Advocacy, Importance of Membership
The story of AHRC Nassau is one of love and relentless advocacy by parent advocates seeking to create a better world for their children with intellectual and developmental disabilities (I/DD). From a small support group of a dozen parents came a...

at 18:00
Nektar to Announce Financial Results for the First Quarter 2024 on Thursday, May 9, 2024, After Close of U.S.-Based Financial Markets
Nektar Therapeutics will announce its financial results for the first quarter 2024 on Thursday, May 9, 2024, after the close of U.S.-based financial markets. Howard Robin, President and Chief Executive Officer, will host a conference call to review...

More news about Health...


News published on and distributed by: